|
Medical care providers are engaged in a constant search for innovative equipment solutions that will provide patients with a superior quality of care. Only by working with the leading specialists within the medical supplier field can they locate these solutions and acquire them directly. And it’s for this reason that care providers across the US are now turning to solutions specialists such as Reliance Medical Systems for next-generation products that will streamline cardiovascular risk assessment and stratification. Reliance Medical Systems is one of the US’s standout providers of high performance medical equipment. The company specializes in delivering solutions that meet their clients’ precise budgetary, environmental and application requirements to perfection and this capability has helped them to develop a large and diverse customer base over their years in operation. This client-base includes hospitals, surgical centers, medical centers and private practitioners, who each depend upon the team at Reliance Medical Systems for solutions ranging from one-off purchases to multi-phase long-term solutions. For example, the company offers some of the industry’s leading cardiology solutions. These solutions include the latest ultrasound cardiac imaging, cardiac defibrillators and monitors, AEDs, cardiac risk assessment tools as well as a service program that offers in office testing including Carotid Doppler, CIMT, ABI for peripheral vascular disease, and more. One of the latest solutions to be added to the company catalogue is the EndoPAT™. This solution is said to be the new industry-standard for assessing endothelial function within patients. While the Framingham Risk Score is often used as a tool to predict future heart problems, it’s has been shown in studies that patients thought to be low risk when assessed using the Framingham Risk Score suffered 300% more adverse cardiac events over a 7 year period if they also had endothelial dysfunction. Now, there’s a way to measure endothelial function and provide better, more accurate risk stratification for cardiovascular disease. No longer do doctors have to assume a patient has Endothelia Dysfunction or that current treatment is addressing this issue. Now they can make an accurate diagnosis and follow improvement through therapy. EndoPAT™ is the industry’s leading product for non-invasive endothelia function testing. The product has been cleared by the FDA and is CE-marked for use in clinics, research centers, and clinical studies in 40 countries around the globe. One of the reasons why so many people now utilize this solution is that it’s highly accurate, exceptionally user-friendly and efficient. Results are automatically calculated and given immediately once the 15-minute in-office test has been completed. Medical professionals trust the results offered by the EndoPat™ product, as proven by the fact that research using EndoPAT™ has yielded over 200 peer reviewed journals and abstracts on the subject of Endothelia Dysfunction. This widespread acknowledgement within the research field has helped the product to become recognized as the standard method for measuring endothelial assessment. The lives of thousands of cardiac patients can now be saved through the use of this innovative diagnosis product. Reliance Medical Systems is the industry’s trusted partner for proven, high performance technology. To learn more about the company’s catalogue, contact the team at Reliance Medical Systems directly. An experienced team member will be delighted to help you find the ideal product. About Reliance Medical Systems: Texas-based Reliance Medical Systems is a leading provider of trusted medical equipment manufactured by the leading names in the industry. To learn more about the company, please visit Reliancemedical. Texas-based Reliance Medical Systems is a leading provider of trusted medical equipment manufactured by the leading names in the industry. To learn more about the company, please visit http://www.reliancemedical.com/.
Related Articles -
Peripheral, Vascular, Disease, Diagnosis,
| 
